Downgrading risk to minimize statin use in an era of increased statin eligibility

19.10.20151887
The 2013 American College of Cardiology/American Heart Association guidelines introduced the 10-year atherosclerotic CVD risk estimator to guide clinician–patient risk discussions about statin therapy.

RIVER-PCI: Ranolazine fails to benefit patients with incomplete revascularization after PCI

15.10.20151689
Treatment with ranolazine did not lower rates of ischemia-driven revascularization or hospitalization without revascularization in patients with a history of chronic angina who had incomplete revascularization after PCI, according to late-breaking clinical trial results presented at the annual TCT Scientific Symposium.

How low should we target the LDL goal to improve survival for acute coronary syndrome patients in Hong Kong?

13.10.20151603
Utilization of lipid-lowering agents has been associated with improved long-term outcomes in acute coronary syndrome (ACS) patients. However, updated data regarding local use and outcomes was lacking.

Rate-Control Treatment and Mortality in Atrial Fibrillation

12.10.20151892
Do rate-control medications affect survival in patients with atrial fibrillation (AF)?

Best Treatment for In-Stent Restenosis

09.10.20151682
What is the best percutaneous treatment for in-stent restenosis (ISR)?

Cardiorenal Function in Heart Failure

07.10.20151627
What are the changes in kidney function in combination with dynamic changes in N-terminal pro–B-type natriuretic peptide (NT-proBNP) when hospitalized for acute decompensated heart failure (ADHF)?

Ankylosing Spondylitis and Cardiovascular Mortality

06.10.20151686
What is the association between ankylosing spondylitis (AS) and excess cardiovascular and cerebrovascular morbidity?
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.